Saudi Arabia will only allow passengers who were vaccinated with Sinopharm or Sinovac vaccines to enter if they received a booster shot from one of the four approved vaccines in the kingdom, according to the Saudi e-visa portal.
Also Read: Saudi Arabia Allowed Sinopharm and Sinovac Vaccinated Travelers
Travellers Vaccinated with Sinopharm, Sinovac Can Enter Saudi Arabia After Booster Shot
Currently, the Kingdom recognizes the following four vaccines: Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson & Johnson vaccines.
Citizens recovering from the Covid-19 are also allowed to travel, given that they had spent less than 6 months infected with the virus, according to what appears in the Tawakkalna application.
The Ministry of Tourism stated on the e-visa portal that guests who have received two doses of the Sinopharm or Sinovac vaccines will be accepted if they have received an additional dose of one of the four vaccines approved in the Kingdom.
Most Trending: Immunized Passengers Coming to Saudi Arabia Must Register on the Vaccination Portal Online
According to the e-visa portal, all travelers entering on a previously issued tourism visa will be required to pay an additional SAR 40 upon arrival at the airport to cover insurance for any COVID-19-related medical expenses.
Passengers will be required to present a negative PCR test result obtained within 72 hours of departure, as well as an approved vaccination certificate issued by the issuing country’s health officials.
Related: Tawakkalna app a must for boarding Flights in Saudi Arabia
Tourists entering the Kingdom are required to register their vaccination records online at https://muqeem.sa/#/vaccine-registration/home. The ministry also said that vaccinated travelers are not required to enter quarantine.
On August 1, Saudi Arabia reopened its borders and began allowing vaccinated tourists.
For the latest updates, you can like our Facebook page
Join our Facebook Food Group Foodaholics - Riyadh and share your experience there.
Have a question to ask? Send message on Facebook.